0
Upcoming Allied Market Research
2023
Transfection Reagents & Equipment Market

Transfection Reagents & Equipment Market

by Product (Reagents, Equipment), by Method (Physical Methods, Biochemical Methods, Viral Methods), by Application (Protein Production, Biomedical Research, Therapeutic Delivery) and by End User (Academics Research Institutes, Pharmaceutical Biotechnology Companies, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A13236
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Transfection Reagents & Equipment Market

Request Now !

Transfection Reagents & Equipment Market Overview 2030

Transfection is the process of introducing genetic material (such as DNA or RNA) into eukaryotic cells to allow the cell's own process to produce proteins in cells. Double-stranded RNA transfection is used to prevent the production of certain proteins by hindering the translation process. The transfection process allows the study of gene function and expression, gene mutation, and protein function. The process of transfection can be divided into stable transfection and transient transfection. Unique membrane active features of transfection reagent are help transfection complex to penetrate the plasma and endocytic membranes in the cell.

COVID-19 Impact Analysis             

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID-19 is expected to have a significant impact on the transfection reagents & equipment market.

Top Impacting Factors

  • Increase in demand for synthetic genes, surge in usage of transfection, rise in popularity of protein therapeutics, increase in incidence of cancer across the globe, rise in geriatric population, and surge in number of commercially available reagents are the major factors that drive the growth of transfection reagents & equipment market.
  • In addition, increase in R & D activities by pharmaceutical & biotechnology companies to develop advance healthcare technology, rise in usage of novel biotechnology techniques, surge in expenses to build advance healthcare facilities, ongoing advancement in cancer research sector to develop effective cancer treatment procedures, and strategic developments by key market players are expected to fuel the growth of transfection reagents & equipment market.
  • However, high cost associated with transfection procedures and lack of awareness regarding transfection methods restrain the growth of transfection reagents & equipment market.
  • Contrarily, rise in novel cancer treatment procedures and government initiatives for regulatory approvals are expected to offer lucrative opportunities for the expansion of the market.

Market Trends

New Product Launches to Flourish the Market

In 2020, Polyplus Transfection SA announced launch of first GMP complient PEIpro transfection reagent. This reagent are designed for process of preclinical, clinical & commercial lentivirus and adeno associated virus for production of cell & gene therapies.

In 2019, Mirus Bio announced launch of new quality TransIT-Virusgen select transfection reagent. This reagent is developed for large scale virus production for preclinical and clinical phase trials.

Key Benefits of the Report

  • This study presents the analytical depiction of transfection reagents & equipment market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the transfection reagents & equipment market share.
  • The current market is quantitatively analyzed to highlight the transfection reagents & equipment market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Transfection Reagents & Equipment Market Report               

  • Which are the leading players active in the transfection reagents & equipment market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "transfection reagents & equipment"?
  • What is "transfection reagents & equipment" market prediction in the future?
  • Who are the leading global players in the "transfection reagents & equipment" market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "transfection reagents & equipment" market report?

Transfection Reagents & Equipment Market Report Highlights

Aspects Details
By Product
  • Reagents
  • Equipment
By Method
  • Physical Methods
  • Biochemical Methods
  • Viral Methods
By Application
  • Protein Production
  • Biomedical Research
  • Therapeutic Delivery
By End User
  • Academics & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Lonza Group Ltd., Qiagen N.V., F. Hoffmann-La Roche Ltd, Promega Corporation, Thermo Fisher Scientific Inc., Bio–Rad Laboratories Inc., PromoCell GmbH, Mirus Bio LLC, OriGene Technologies Inc., Merck KGaA
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Reagents

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Equipment

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHOD

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Method

    • 5.2. Physical Methods

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Biochemical Methods

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Viral Methods

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Protein Production

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Biomedical Research

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Therapeutic Delivery

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Academics Research Institutes

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Pharmaceutical Biotechnology Companies

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Others

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

  • CHAPTER 8: TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Product

      • 8.2.3. Market Size and Forecast, By Method

      • 8.2.4. Market Size and Forecast, By Application

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Transfection Reagents And Equipment Market

        • 8.2.7.1. Market Size and Forecast, By Product
        • 8.2.7.2. Market Size and Forecast, By Method
        • 8.2.7.3. Market Size and Forecast, By Application
        • 8.2.7.4. Market Size and Forecast, By End User
      • 8.2.8. Canada Transfection Reagents And Equipment Market

        • 8.2.8.1. Market Size and Forecast, By Product
        • 8.2.8.2. Market Size and Forecast, By Method
        • 8.2.8.3. Market Size and Forecast, By Application
        • 8.2.8.4. Market Size and Forecast, By End User
      • 8.2.9. Mexico Transfection Reagents And Equipment Market

        • 8.2.9.1. Market Size and Forecast, By Product
        • 8.2.9.2. Market Size and Forecast, By Method
        • 8.2.9.3. Market Size and Forecast, By Application
        • 8.2.9.4. Market Size and Forecast, By End User
    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Product

      • 8.3.3. Market Size and Forecast, By Method

      • 8.3.4. Market Size and Forecast, By Application

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Transfection Reagents And Equipment Market

        • 8.3.7.1. Market Size and Forecast, By Product
        • 8.3.7.2. Market Size and Forecast, By Method
        • 8.3.7.3. Market Size and Forecast, By Application
        • 8.3.7.4. Market Size and Forecast, By End User
      • 8.3.8. Germany Transfection Reagents And Equipment Market

        • 8.3.8.1. Market Size and Forecast, By Product
        • 8.3.8.2. Market Size and Forecast, By Method
        • 8.3.8.3. Market Size and Forecast, By Application
        • 8.3.8.4. Market Size and Forecast, By End User
      • 8.3.9. Italy Transfection Reagents And Equipment Market

        • 8.3.9.1. Market Size and Forecast, By Product
        • 8.3.9.2. Market Size and Forecast, By Method
        • 8.3.9.3. Market Size and Forecast, By Application
        • 8.3.9.4. Market Size and Forecast, By End User
      • 8.3.10. Spain Transfection Reagents And Equipment Market

        • 8.3.10.1. Market Size and Forecast, By Product
        • 8.3.10.2. Market Size and Forecast, By Method
        • 8.3.10.3. Market Size and Forecast, By Application
        • 8.3.10.4. Market Size and Forecast, By End User
      • 8.3.11. UK Transfection Reagents And Equipment Market

        • 8.3.11.1. Market Size and Forecast, By Product
        • 8.3.11.2. Market Size and Forecast, By Method
        • 8.3.11.3. Market Size and Forecast, By Application
        • 8.3.11.4. Market Size and Forecast, By End User
      • 8.3.12. Russia Transfection Reagents And Equipment Market

        • 8.3.12.1. Market Size and Forecast, By Product
        • 8.3.12.2. Market Size and Forecast, By Method
        • 8.3.12.3. Market Size and Forecast, By Application
        • 8.3.12.4. Market Size and Forecast, By End User
      • 8.3.13. Rest Of Europe Transfection Reagents And Equipment Market

        • 8.3.13.1. Market Size and Forecast, By Product
        • 8.3.13.2. Market Size and Forecast, By Method
        • 8.3.13.3. Market Size and Forecast, By Application
        • 8.3.13.4. Market Size and Forecast, By End User
    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Product

      • 8.4.3. Market Size and Forecast, By Method

      • 8.4.4. Market Size and Forecast, By Application

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Transfection Reagents And Equipment Market

        • 8.4.7.1. Market Size and Forecast, By Product
        • 8.4.7.2. Market Size and Forecast, By Method
        • 8.4.7.3. Market Size and Forecast, By Application
        • 8.4.7.4. Market Size and Forecast, By End User
      • 8.4.8. Japan Transfection Reagents And Equipment Market

        • 8.4.8.1. Market Size and Forecast, By Product
        • 8.4.8.2. Market Size and Forecast, By Method
        • 8.4.8.3. Market Size and Forecast, By Application
        • 8.4.8.4. Market Size and Forecast, By End User
      • 8.4.9. India Transfection Reagents And Equipment Market

        • 8.4.9.1. Market Size and Forecast, By Product
        • 8.4.9.2. Market Size and Forecast, By Method
        • 8.4.9.3. Market Size and Forecast, By Application
        • 8.4.9.4. Market Size and Forecast, By End User
      • 8.4.10. South Korea Transfection Reagents And Equipment Market

        • 8.4.10.1. Market Size and Forecast, By Product
        • 8.4.10.2. Market Size and Forecast, By Method
        • 8.4.10.3. Market Size and Forecast, By Application
        • 8.4.10.4. Market Size and Forecast, By End User
      • 8.4.11. Australia Transfection Reagents And Equipment Market

        • 8.4.11.1. Market Size and Forecast, By Product
        • 8.4.11.2. Market Size and Forecast, By Method
        • 8.4.11.3. Market Size and Forecast, By Application
        • 8.4.11.4. Market Size and Forecast, By End User
      • 8.4.12. Thailand Transfection Reagents And Equipment Market

        • 8.4.12.1. Market Size and Forecast, By Product
        • 8.4.12.2. Market Size and Forecast, By Method
        • 8.4.12.3. Market Size and Forecast, By Application
        • 8.4.12.4. Market Size and Forecast, By End User
      • 8.4.13. Malaysia Transfection Reagents And Equipment Market

        • 8.4.13.1. Market Size and Forecast, By Product
        • 8.4.13.2. Market Size and Forecast, By Method
        • 8.4.13.3. Market Size and Forecast, By Application
        • 8.4.13.4. Market Size and Forecast, By End User
      • 8.4.14. Indonesia Transfection Reagents And Equipment Market

        • 8.4.14.1. Market Size and Forecast, By Product
        • 8.4.14.2. Market Size and Forecast, By Method
        • 8.4.14.3. Market Size and Forecast, By Application
        • 8.4.14.4. Market Size and Forecast, By End User
      • 8.4.15. Rest of Asia Pacific Transfection Reagents And Equipment Market

        • 8.4.15.1. Market Size and Forecast, By Product
        • 8.4.15.2. Market Size and Forecast, By Method
        • 8.4.15.3. Market Size and Forecast, By Application
        • 8.4.15.4. Market Size and Forecast, By End User
    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Product

      • 8.5.3. Market Size and Forecast, By Method

      • 8.5.4. Market Size and Forecast, By Application

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Transfection Reagents And Equipment Market

        • 8.5.7.1. Market Size and Forecast, By Product
        • 8.5.7.2. Market Size and Forecast, By Method
        • 8.5.7.3. Market Size and Forecast, By Application
        • 8.5.7.4. Market Size and Forecast, By End User
      • 8.5.8. South Africa Transfection Reagents And Equipment Market

        • 8.5.8.1. Market Size and Forecast, By Product
        • 8.5.8.2. Market Size and Forecast, By Method
        • 8.5.8.3. Market Size and Forecast, By Application
        • 8.5.8.4. Market Size and Forecast, By End User
      • 8.5.9. Saudi Arabia Transfection Reagents And Equipment Market

        • 8.5.9.1. Market Size and Forecast, By Product
        • 8.5.9.2. Market Size and Forecast, By Method
        • 8.5.9.3. Market Size and Forecast, By Application
        • 8.5.9.4. Market Size and Forecast, By End User
      • 8.5.10. UAE Transfection Reagents And Equipment Market

        • 8.5.10.1. Market Size and Forecast, By Product
        • 8.5.10.2. Market Size and Forecast, By Method
        • 8.5.10.3. Market Size and Forecast, By Application
        • 8.5.10.4. Market Size and Forecast, By End User
      • 8.5.11. Argentina Transfection Reagents And Equipment Market

        • 8.5.11.1. Market Size and Forecast, By Product
        • 8.5.11.2. Market Size and Forecast, By Method
        • 8.5.11.3. Market Size and Forecast, By Application
        • 8.5.11.4. Market Size and Forecast, By End User
      • 8.5.12. Rest of LAMEA Transfection Reagents And Equipment Market

        • 8.5.12.1. Market Size and Forecast, By Product
        • 8.5.12.2. Market Size and Forecast, By Method
        • 8.5.12.3. Market Size and Forecast, By Application
        • 8.5.12.4. Market Size and Forecast, By End User
  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Thermo Fisher Scientific Inc.

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. F. Hoffmann-La Roche Ltd

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Promega Corporation

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Bio–Rad Laboratories Inc.

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Qiagen N.V.

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Merck KGaA

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Lonza Group Ltd.

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Mirus Bio LLC

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. OriGene Technologies Inc.

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. PromoCell GmbH

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR PHYSICAL METHODS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR BIOCHEMICAL METHODS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR VIRAL METHODS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR PROTEIN PRODUCTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR ACADEMICS RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 22. U.S. TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 23. U.S. TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 24. U.S. TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. U.S. TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. CANADA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. CANADA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 28. CANADA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. CANADA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. MEXICO TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 35. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. FRANCE TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 41. FRANCE TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 45. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. ITALY TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 48. ITALY TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 49. ITALY TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. ITALY TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. SPAIN TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. SPAIN TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 53. SPAIN TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. SPAIN TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. UK TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. UK TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 57. UK TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. UK TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. RUSSIA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. RUSSIA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 61. RUSSIA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. RUSSIA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. REST OF EUROPE TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. REST OF EUROPE TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 65. REST OF EUROPE TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. REST OF EUROPE TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 68. ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 70. ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. CHINA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 73. CHINA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 74. CHINA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. CHINA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 77. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 78. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. INDIA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. INDIA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 82. INDIA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. INDIA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH KOREA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH KOREA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH KOREA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH KOREA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. AUSTRALIA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 89. AUSTRALIA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 90. AUSTRALIA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. AUSTRALIA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. THAILAND TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 93. THAILAND TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 94. THAILAND TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. THAILAND TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. MALAYSIA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 97. MALAYSIA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 98. MALAYSIA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 99. MALAYSIA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. INDONESIA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 101. INDONESIA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 102. INDONESIA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 103. INDONESIA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 105. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 106. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 107. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. LAMEA TRANSFECTION REAGENTS AND EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 109. LAMEA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 110. LAMEA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 111. LAMEA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 112. LAMEA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 113. BRAZIL TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 114. BRAZIL TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 115. BRAZIL TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 116. BRAZIL TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 117. SOUTH AFRICA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 118. SOUTH AFRICA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 119. SOUTH AFRICA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 120. SOUTH AFRICA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 121. SAUDI ARABIA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 122. SAUDI ARABIA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 123. SAUDI ARABIA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 124. SAUDI ARABIA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 125. UAE TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 126. UAE TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 127. UAE TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 128. UAE TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 129. ARGENTINA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 130. ARGENTINA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 131. ARGENTINA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 132. ARGENTINA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 133. REST OF LAMEA TRANSFECTION REAGENTS AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 134. REST OF LAMEA TRANSFECTION REAGENTS AND EQUIPMENT, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 135. REST OF LAMEA TRANSFECTION REAGENTS AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 136. REST OF LAMEA TRANSFECTION REAGENTS AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 137. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 138. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 139. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 140. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 141. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES
  • TABLE 143. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
  • TABLE 144. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
  • TABLE 145. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
  • TABLE 146. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. PROMEGA CORPORATION: KEY EXECUTIVES
  • TABLE 148. PROMEGA CORPORATION: COMPANY SNAPSHOT
  • TABLE 149. PROMEGA CORPORATION: OPERATING SEGMENTS
  • TABLE 150. PROMEGA CORPORATION: PRODUCT PORTFOLIO
  • TABLE 151. PROMEGA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. BIO–RAD LABORATORIES INC.: KEY EXECUTIVES
  • TABLE 153. BIO–RAD LABORATORIES INC.: COMPANY SNAPSHOT
  • TABLE 154. BIO–RAD LABORATORIES INC.: OPERATING SEGMENTS
  • TABLE 155. BIO–RAD LABORATORIES INC.: PRODUCT PORTFOLIO
  • TABLE 156. BIO–RAD LABORATORIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. QIAGEN N.V.: KEY EXECUTIVES
  • TABLE 158. QIAGEN N.V.: COMPANY SNAPSHOT
  • TABLE 159. QIAGEN N.V.: OPERATING SEGMENTS
  • TABLE 160. QIAGEN N.V.: PRODUCT PORTFOLIO
  • TABLE 161. QIAGEN N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 162. MERCK KGAA: KEY EXECUTIVES
  • TABLE 163. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 164. MERCK KGAA: OPERATING SEGMENTS
  • TABLE 165. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 166. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 167. LONZA GROUP LTD.: KEY EXECUTIVES
  • TABLE 168. LONZA GROUP LTD.: COMPANY SNAPSHOT
  • TABLE 169. LONZA GROUP LTD.: OPERATING SEGMENTS
  • TABLE 170. LONZA GROUP LTD.: PRODUCT PORTFOLIO
  • TABLE 171. LONZA GROUP LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 172. MIRUS BIO LLC: KEY EXECUTIVES
  • TABLE 173. MIRUS BIO LLC: COMPANY SNAPSHOT
  • TABLE 174. MIRUS BIO LLC: OPERATING SEGMENTS
  • TABLE 175. MIRUS BIO LLC: PRODUCT PORTFOLIO
  • TABLE 176. MIRUS BIO LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 177. ORIGENE TECHNOLOGIES INC.: KEY EXECUTIVES
  • TABLE 178. ORIGENE TECHNOLOGIES INC.: COMPANY SNAPSHOT
  • TABLE 179. ORIGENE TECHNOLOGIES INC.: OPERATING SEGMENTS
  • TABLE 180. ORIGENE TECHNOLOGIES INC.: PRODUCT PORTFOLIO
  • TABLE 181. ORIGENE TECHNOLOGIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 182. PROMOCELL GMBH: KEY EXECUTIVES
  • TABLE 183. PROMOCELL GMBH: COMPANY SNAPSHOT
  • TABLE 184. PROMOCELL GMBH: OPERATING SEGMENTS
  • TABLE 185. PROMOCELL GMBH: PRODUCT PORTFOLIO
  • TABLE 186. PROMOCELL GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET SEGMENTATION
  • FIGURE 2. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET
  • FIGURE 3. SEGMENTATION TRANSFECTION REAGENTS AND EQUIPMENT MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALTRANSFECTION REAGENTS AND EQUIPMENT MARKET
  • FIGURE 11. TRANSFECTION REAGENTS AND EQUIPMENT MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR REAGENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR EQUIPMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. TRANSFECTION REAGENTS AND EQUIPMENT MARKET SEGMENTATION, BY BY METHOD
  • FIGURE 15. TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR PHYSICAL METHODS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR BIOCHEMICAL METHODS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR VIRAL METHODS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. TRANSFECTION REAGENTS AND EQUIPMENT MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 19. TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. TRANSFECTION REAGENTS AND EQUIPMENT MARKET SEGMENTATION, BY BY END USER
  • FIGURE 23. TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR ACADEMICS RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. TRANSFECTION REAGENTS AND EQUIPMENT MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: TRANSFECTION REAGENTS AND EQUIPMENT MARKET
  • FIGURE 32. Top player positioning, 2022
  • FIGURE 33. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. PROMEGA CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. PROMEGA CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. PROMEGA CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. BIO–RAD LABORATORIES INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. BIO–RAD LABORATORIES INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. BIO–RAD LABORATORIES INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. QIAGEN N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. QIAGEN N.V.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. QIAGEN N.V.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. MERCK KGAA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. LONZA GROUP LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. LONZA GROUP LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. LONZA GROUP LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. MIRUS BIO LLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. MIRUS BIO LLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. MIRUS BIO LLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. ORIGENE TECHNOLOGIES INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. ORIGENE TECHNOLOGIES INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. ORIGENE TECHNOLOGIES INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. PROMOCELL GMBH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. PROMOCELL GMBH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. PROMOCELL GMBH: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Transfection Reagents & Equipment Market

Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers